Editorial
Editorial on “Quantitative Analysis of Orbital Soft Tissues Using Three-Dimensional Fast Spin Echo With 2-Point Dixon-Based Fat Suppression Sequence: Its Association With Methylprednisolone Pulse Therapy Treatment Efficacy in Thyroid-Associated Ophthalmopathy”
Sophie C. Queler,
Ek T. Tan,
Sophie C. Queler
Department of Radiology & Imaging, Hospital for Special Surgery, New York, New York, USA
Search for more papers by this authorCorresponding Author
Ek T. Tan
Department of Radiology & Imaging, Hospital for Special Surgery, New York, New York, USA
Correspondence:
Ek T. Tan ([email protected])
Search for more papers by this authorSophie C. Queler,
Ek T. Tan,
Sophie C. Queler
Department of Radiology & Imaging, Hospital for Special Surgery, New York, New York, USA
Search for more papers by this authorCorresponding Author
Ek T. Tan
Department of Radiology & Imaging, Hospital for Special Surgery, New York, New York, USA
Correspondence:
Ek T. Tan ([email protected])
Search for more papers by this authorFirst published: 01 April 2025
No abstract is available for this article.
References
- 1M. L. Tanda, E. Piantanida, L. Liparulo, et al., “Prevalence and Natural History of Graves' Orbitopathy in a Large Series of Patients With Newly Diagnosed Graves' Hyperthyroidism Seen at a Single Center,” Journal of Clinical Endocrinology and Metabolism 98, no. 4 (2013): 1443–1449, https://doi.org/10.1210/jc.2012-3873.
- 2L. Bartalena, E. Piantanida, D. Gallo, A. Lai, and M. L. Tanda, “Epidemiology, Natural History, Risk Factors, and Prevention of Graves' Orbitopathy,” Frontiers in Endocrinology 11 (2020): 615993, https://doi.org/10.3389/fendo.2020.615993.
- 3S. Zang, K. A. Ponto, and G. J. Kahaly, “Clinical Review: Intravenous Glucocorticoids for Graves' Orbitopathy: Efficacy and Morbidity,” Journal of Clinical Endocrinology and Metabolism 96, no. 2 (2011): 320–332, https://doi.org/10.1210/jc.2010-1962.
- 4H. Zhang, T. Lu, Y. Liu, et al., “Application of Quantitative MRI in Thyroid Eye Disease: Imaging Techniques and Clinical Practices,” Journal of Magnetic Resonance Imaging 60, no. 3 (2024): 827–847, https://doi.org/10.1002/jmri.29114.
- 5A. Ollitrault, F. Charbonneau, M. L. Herdan, et al., “Dixon-T2WI Magnetic Resonance Imaging at 3 Tesla Outperforms Conventional Imaging for Thyroid Eye Disease,” European Radiology 31, no. 7 (2021): 5198–5205, https://doi.org/10.1007/s00330-020-07540-y.
- 6L. Chen, H. Hu, H. H. Chen, et al., “Usefulness of Two-Point Dixon T2-Weighted Imaging in Thyroid-Associated Ophthalmopathy: Comparison With Conventional Fat Saturation Imaging in Fat Suppression Quality and Staging Performance,” British Journal of Radiology 94, no. 1118 (2021): 20200884, https://doi.org/10.1259/bjr.20200884.
- 7Y. Chen, L. Zhai, W. Liang, et al., “Quantitative Analysis of Orbital Soft Tissues Using Three-Dimensional Fast Spin Echo With 2-Point Dixon-Based Fat Suppression Sequence: Its Association With Methylprednisolone Pulse Therapy Treatment Efficacy in Thyroid-Associated Ophthalmopathy,” Journal of Magnetic Resonance Imaging 62, no. 2 (2025): 389–400, https://doi.org/10.1002/jmri.29735.
- 8L. Zhai, B. Luo, H. Wu, et al., “Prediction of Treatment Response to Intravenous Glucocorticoid in Patients With Thyroid-Associated Ophthalmopathy Using T2 Mapping and T2 IDEAL,” European Journal of Radiology 142 (2021): 109839, https://doi.org/10.1016/j.ejrad.2021.109839.
- 9T. Higashiyama, Y. Nishida, and M. Ohji, “Changes of Orbital Tissue Volumes and Proptosis in Patients With Thyroid Extraocular Muscle Swelling After Methylprednisolone Pulse Therapy,” Japanese Journal of Ophthalmology 59, no. 6 (2015): 430–435, https://doi.org/10.1007/s10384-015-0410-4.
- 10R. S. Douglas, S. Couch, S. T. Wester, et al., “Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease Activity,” Journal of Clinical Endocrinology and Metabolism 109, no. 1 (2023): 25–35, https://doi.org/10.1210/clinem/dgad637.
